DC
Cytopeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cyto-MSC Acute Stroke | Acute Ischemic Stroke | Phase 2 |
| Cyto-MSC Diabetes Complications | Diabetes-related Vascular Complications | Phase 2 |
| Cyto-MSC Knee Osteoarthritis | Knee Osteoarthritis | Phase 2 |
| CIK Cell Immunotherapy | Solid Tumor Oncology | Phase 1 |
| M2 Macrophage Therapy | Graft‑Versus‑Host Disease (GVHD) | Phase 1 |